Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Haemonetics Corp. buy BTIG Research

Start price
€66.50
10.09.24 / 50%
Target price
€101.52
10.09.25
Performance (%)
-32.03%
End price
€45.20
11.09.25
Summary
This prediction ended on 11.09.25 with a price of €45.20. Massive losses of -32.03% were the result for the BUY prediction by BTIG_Research. BTIG_Research has a follow-up prediction for Haemonetics Corp. where he still thinks Haemonetics Corp. is a Buy. BTIG_Research has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y
Haemonetics Corp. - - -
iShares Core DAX® -1.601% -2.870% 23.766%
iShares Nasdaq 100 -3.257% 2.028% 12.826%
iShares Nikkei 225® -1.085% 3.422% 18.100%
iShares S&P 500 -1.858% 1.235% 6.568%

Comments by BTIG_Research for this prediction

In the thread Haemonetics Corp. diskutieren
Prediction Buy
Perf. (%) -32.03%
Target price 101.517
Change
Ends at 10.09.25

Haemonetics Co. (NYSE: HAE) is now covered by analysts at BTIG Research. They set a "buy" rating and a $112.00 price target on the stock.
Ratings data for HAE provided by MarketBeat

In the thread Trading Haemonetics Corp.
Prediction Buy
Perf. (%) -32.03%
Target price 101.517
Change
Ends at 10.09.25

Die von BTIG_Research gewählte maximale Laufzeit wurde überschritten

Current prediction by BTIG_Research for Haemonetics Corp.

buy
Haemonetics Corp.

Start price
Target price
Perf. (%)
€57.50
06.11.25
€76.46
06.11.26
4.35%
16:02